Kevin Chidwick, the Chief Financial Officer of FTSE 100 insurance giant Admiral Group, has traded in 37,500 of the 50,000 shares he was awarded under the group's discretionary free share scheme. Chidwick disposed of the shares at 1,350p each, generating proceeds of £506,250. His deputy, Geraint Jones, was awarded 16,000 and sold 7,520 at the same price, while Chief Executive Officer of the group's Italian direct insurance business, ConTe.it, sold all 12,000 she was awarded. Finally, Cristina Nestares, the Chief Executive Officer of the Group's Spanish direct insurance business, Admiral Seguros, was awarded 25,000 shares and sold 18,750.The company said 100% of the award for Kevin Chidwick and 50% of the awards for Jones, Mondini and Nestares were subject to group performance conditions from January 1st 2011 to December 31st 2013. Top Director BuysAdvanced Oncotherapy (AVO) Director name: Mr Michael Bradfield Amount purchased: 18,518,510 @ 2.70p Value: £500,000Advanced Oncotherapy (AVO) Director name: Dr Michael J SinclairAmount purchased: 2,963,000 @ 2.70p Value: £80,001Advanced Oncotherapy (AVO) Director name: Dr Michael J SinclairAmount purchased: 2,963,000 @ 2.70p Value: £80,001Advanced Oncotherapy (AVO) Director name: Lord David Evans of WatfordAmount purchased: 740,750 @ 2.70p Value: £20,000Advanced Oncotherapy (AVO) Director name: Professor Christopher Nutting Amount purchased: 370,400 @ 2.70p Value: £10,001Advanced Oncotherapy (AVO) Director name: Mr Sanjeev Pandya Amount purchased: 370,400 @ 2.70p Value: £10,001Top Director SellsAdmiral Group (ADM) Director name: Mr Kevin ChidwickAmount sold: 37,500 @ 1,350.15p Value: £506,306NR